About
Florian Müellershausen PhD is a Managing Director at the Novartis Venture Fund in Basel, Switzerland. Prior to joining NVF, he worked as a Scientific Manager for the R&D Committee of the Novartis Board of Directors. Before that, he held various drug discovery roles in Novartis R&D including positions as Laboratory Head in target discovery and as Translational Medicine Expert, Autoimmunity in early clinical research. Florian received his MSc degree in Biochemistry from Free University Berlin, his PhD with great distinction in Biochemistry from Ruhr University Bochum, and his postdoctoral training at Novartis in Switzerland.
Investments
- Anaveon (Board Director)
- Granite Bio (Board Director)
- LoQus23 Therapeutics (Board Director)
- Fundamental Pharma (Observer)
- RhyGaze (Board Director)
Successes
- Arctos Medical AG (Acquired by Novartis)